Alliqua Inc (ALQA) 6.64 $ALQA
Alliqua Reports First Quarter 2014 Financial Results
GlobeNewswire - Mon May 12, 6:30AM CDT
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
, a provider of advanced wound care products, today announced financial results for the first quarter ended March 31, 2014.
Alliqua Acquires Choice Therapeutics
GlobeNewswire - Tue May 06, 6:43AM CDT
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or the "Company" , a provider of advanced wound care products, has acquired Choice Therapeutics, Inc. ("Choice Therapeutics" , a privately held wound care company with proprietary technologies and products, for approximately $4 million in stock and cash. The merger agreement, which became effective May 5, 2014, provides for additional contingent payments of up to $5 million in stock or cash, under certain circumstances, if stated revenue thresholds are reached over the next three years ending April 30, 2017. The acquisition is expected to be accretive to Alliqua's earnings during the next 12 months.
Alliqua to Launch Biovance(R) Human Amniotic Membrane Allograft Product Licensed From Celgene
GlobeNewswire - Wed Apr 23, 6:30AM CDT
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company" , a provider of advanced wound care products, will launch its Biovance human amniotic membrane allograft product at Booth #1208 at the Spring 2014 Symposium on Advanced Wound Care to be held at the Gaylord Palms Hotel and Convention Center in Orlando, Florida on April 23-27.
Alliqua Biomedical Announces New Data on sorbion(R) Wound Care Dressings to be Presented at the Spring 2014 SAWC Meeting
GlobeNewswire - Mon Apr 21, 6:30AM CDT
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company" , a provider of advanced wound care products, announces new data from the Company's sorbion product line will be presented at the Spring 2014 Symposium on Advanced Wound Care to be held at the Gaylord Palms Hotel and Convention Center in Orlando, Florida on April 23-27. Thirteen abstracts will highlight data on cytokine and protease binding capabilities and bacterial sequestration and retention through exudate management by sorbion dressings. The resulting reduction of inflammation and impact on other factors that affect wound healing will be discussed.
Nasdaq stocks posting largest percentage increases
AP - Wed Apr 16, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
UPDATE -- Alliqua Raises $20.3 Million in Private Placement of Equity and Exercise of Warrants
GlobeNewswire - Tue Apr 15, 10:14AM CDT
In a release issued earlier today under the same headline by Alliqua, Inc. (Nasdaq:ALQA), please note that details of the common stock price of $7.00 per share have been added to paragraph two. The updated release follows.
Alliqua Raises $20.3 Million in Private Placement of Equity and Exercise of Warrants
GlobeNewswire - Tue Apr 15, 7:55AM CDT
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or the "Company" , a provider of advanced wound care products, has raised $20.3 million in a series of transactions that included a $15.0 million private placement of common stock and warrants and $5.3 million from the exercise of warrants from several institutional shareholders.
Alliqua Appoints 20 Direct Sales Representatives to Strengthen Brand Awareness and Drive Greater Market Penetration in the U.S.
GlobeNewswire - Mon Mar 31, 6:30AM CDT
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or the "Company" , a provider of advanced wound care products, has hired a 20-member direct sales force to further strengthen the Company's brand awareness, increase brand adoption and drive greater market penetration in the United States. The new sales team members come to Alliqua with vast experience in the healthcare space and a successful history of navigating the U.S. healthcare sales cycle.
Alliqua Reports Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Mon Mar 24, 6:30AM CDT
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company" , a provider of advanced wound care products and custom manufacturing solutions to partners in the medical device and cosmetics industry, reports its financial results for the quarter and year ended December 31, 2013.
EquitiesIQ Interviews David Johnson, CEO of Alliqua
ACCESSWIRE - Wed Mar 19, 12:30PM CDT
Watch the Interview: http://equitiesiq.com/alliqua-interview/
Alliqua to Present at 26th Annual ROTH Conference on March 10
GlobeNewswire - Mon Mar 03, 6:01AM CST
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company" announces that David Johnson, Chief Executive Officer, will present at the 26th Annual ROTH Conference at The Ritz-Carlton in Laguna Niguel, CA. Mr. Johnson is scheduled to present on Monday, March 10 at 2:00 pm PT (5:00 pm ET) in Track 6, Salon 6.
Alliqua, Inc. [ALQA] to Ring The NASDAQ Stock Market Opening Bell
GlobeNewswire - Fri Feb 21, 9:00AM CST
What:
Alliqua, Inc. Profiled by TheStreet.com and Philadelphia Business Journal
Business Wire - Thu Feb 13, 6:00AM CST
Alliqua, Inc. (NASDAQ:ALQA) ("Alliqua" or the "Company" was featured in a video interview published by TheStreet.com and in an article published by the Philadelphia Business Journal.
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into ALLIQUA, INC. Regarding Possible Breaches of Fiduciary Duty
PR Newswire - Tue Feb 11, 11:01AM CST
Levi & Korsinsky, LLP is investigating Alliqua, Inc. (NasdaqCM: ALQA) in connection with possible claims of breaches of fiduciary duty by the board of directors of the Company.
Alliqua names Janice M Smiell as company's first chief medical officer
M2 - Tue Feb 11, 7:29AM CST
US-based wound care and drug delivery specialists Alliqua Inc (Nasdaq:ALQA) announced on Monday the appointment of Janice M Smiell MD to the newly created position of chief medical officer.
SeraCare Life Sciences and Dr. Jack Wands Spark Advancements in Oncology Diagnostics
PR Newswire - Tue Feb 11, 7:00AM CST
SeraCare Life Sciences, a provider of high quality biological materials and reagents that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today introduced Dr. Jack Wands as the founding member of the SeraCare Science Advisory Board. This group will bring together thought leaders in emerging technologies and applications such as NexGen sequencing, clinical oncology and autoimmune disease to foster collaboration and innovation.
Alliqua Appoints Janice M. Smiell, M.D. as its First Chief Medical Officer
Business Wire - Mon Feb 10, 6:00AM CST
Alliqua, Inc. (NASDAQ:ALQA) ("Alliqua" or "the Company" has appointed Janice M. Smiell, M.D. as its Chief Medical Officer, a newly created position.
Alliqua's CEO Issues Letter to Shareholders
Business Wire - Mon Feb 03, 6:30AM CST
David Johnson, CEO of Alliqua, Inc. (NASDAQ:ALQA) ("Alliqua" or "the Company" , has issued the following letter to shareholders:
10-Q: MISTRAS GROUP, INC.
Edgar Online - Thu Jan 09, 3:07PM CST
ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Alliqua Reports First Quarter 2014 Financial Results
GlobeNewswire - Mon May 12, 6:30AM CDT
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
, a provider of advanced wound care products, today announced financial results for the first quarter ended March 31, 2014. Alliqua Acquires Choice Therapeutics
GlobeNewswire - Tue May 06, 6:43AM CDT
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or the "Company"
, a provider of advanced wound care products, has acquired Choice Therapeutics, Inc. ("Choice Therapeutics" , a privately held wound care company with proprietary technologies and products, for approximately $4 million in stock and cash. The merger agreement, which became effective May 5, 2014, provides for additional contingent payments of up to $5 million in stock or cash, under certain circumstances, if stated revenue thresholds are reached over the next three years ending April 30, 2017. The acquisition is expected to be accretive to Alliqua's earnings during the next 12 months. Alliqua to Launch Biovance(R) Human Amniotic Membrane Allograft Product Licensed From Celgene
GlobeNewswire - Wed Apr 23, 6:30AM CDT
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
, a provider of advanced wound care products, will launch its Biovance human amniotic membrane allograft product at Booth #1208 at the Spring 2014 Symposium on Advanced Wound Care to be held at the Gaylord Palms Hotel and Convention Center in Orlando, Florida on April 23-27. Alliqua Biomedical Announces New Data on sorbion(R) Wound Care Dressings to be Presented at the Spring 2014 SAWC Meeting
GlobeNewswire - Mon Apr 21, 6:30AM CDT
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
, a provider of advanced wound care products, announces new data from the Company's sorbion product line will be presented at the Spring 2014 Symposium on Advanced Wound Care to be held at the Gaylord Palms Hotel and Convention Center in Orlando, Florida on April 23-27. Thirteen abstracts will highlight data on cytokine and protease binding capabilities and bacterial sequestration and retention through exudate management by sorbion dressings. The resulting reduction of inflammation and impact on other factors that affect wound healing will be discussed. Nasdaq stocks posting largest percentage increases
AP - Wed Apr 16, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
UPDATE -- Alliqua Raises $20.3 Million in Private Placement of Equity and Exercise of Warrants
GlobeNewswire - Tue Apr 15, 10:14AM CDT
In a release issued earlier today under the same headline by Alliqua, Inc. (Nasdaq:ALQA), please note that details of the common stock price of $7.00 per share have been added to paragraph two. The updated release follows.
Alliqua Raises $20.3 Million in Private Placement of Equity and Exercise of Warrants
GlobeNewswire - Tue Apr 15, 7:55AM CDT
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or the "Company"
, a provider of advanced wound care products, has raised $20.3 million in a series of transactions that included a $15.0 million private placement of common stock and warrants and $5.3 million from the exercise of warrants from several institutional shareholders. Alliqua Appoints 20 Direct Sales Representatives to Strengthen Brand Awareness and Drive Greater Market Penetration in the U.S.
GlobeNewswire - Mon Mar 31, 6:30AM CDT
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or the "Company"
, a provider of advanced wound care products, has hired a 20-member direct sales force to further strengthen the Company's brand awareness, increase brand adoption and drive greater market penetration in the United States. The new sales team members come to Alliqua with vast experience in the healthcare space and a successful history of navigating the U.S. healthcare sales cycle. Alliqua Reports Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Mon Mar 24, 6:30AM CDT
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
, a provider of advanced wound care products and custom manufacturing solutions to partners in the medical device and cosmetics industry, reports its financial results for the quarter and year ended December 31, 2013. EquitiesIQ Interviews David Johnson, CEO of Alliqua
ACCESSWIRE - Wed Mar 19, 12:30PM CDT
Watch the Interview: http://equitiesiq.com/alliqua-interview/
Alliqua to Present at 26th Annual ROTH Conference on March 10
GlobeNewswire - Mon Mar 03, 6:01AM CST
Alliqua, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"
announces that David Johnson, Chief Executive Officer, will present at the 26th Annual ROTH Conference at The Ritz-Carlton in Laguna Niguel, CA. Mr. Johnson is scheduled to present on Monday, March 10 at 2:00 pm PT (5:00 pm ET) in Track 6, Salon 6. Alliqua, Inc. [ALQA] to Ring The NASDAQ Stock Market Opening Bell
GlobeNewswire - Fri Feb 21, 9:00AM CST
What:
Alliqua, Inc. Profiled by TheStreet.com and Philadelphia Business Journal
Business Wire - Thu Feb 13, 6:00AM CST
Alliqua, Inc. (NASDAQ:ALQA) ("Alliqua" or the "Company"
was featured in a video interview published by TheStreet.com and in an article published by the Philadelphia Business Journal. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into ALLIQUA, INC. Regarding Possible Breaches of Fiduciary Duty
PR Newswire - Tue Feb 11, 11:01AM CST
Levi & Korsinsky, LLP is investigating Alliqua, Inc. (NasdaqCM: ALQA) in connection with possible claims of breaches of fiduciary duty by the board of directors of the Company.
Alliqua names Janice M Smiell as company's first chief medical officer
M2 - Tue Feb 11, 7:29AM CST
US-based wound care and drug delivery specialists Alliqua Inc (Nasdaq:ALQA) announced on Monday the appointment of Janice M Smiell MD to the newly created position of chief medical officer.
SeraCare Life Sciences and Dr. Jack Wands Spark Advancements in Oncology Diagnostics
PR Newswire - Tue Feb 11, 7:00AM CST
SeraCare Life Sciences, a provider of high quality biological materials and reagents that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today introduced Dr. Jack Wands as the founding member of the SeraCare Science Advisory Board. This group will bring together thought leaders in emerging technologies and applications such as NexGen sequencing, clinical oncology and autoimmune disease to foster collaboration and innovation.
Alliqua Appoints Janice M. Smiell, M.D. as its First Chief Medical Officer
Business Wire - Mon Feb 10, 6:00AM CST
Alliqua, Inc. (NASDAQ:ALQA) ("Alliqua" or "the Company"
has appointed Janice M. Smiell, M.D. as its Chief Medical Officer, a newly created position. Alliqua's CEO Issues Letter to Shareholders
Business Wire - Mon Feb 03, 6:30AM CST
David Johnson, CEO of Alliqua, Inc. (NASDAQ:ALQA) ("Alliqua" or "the Company"
, has issued the following letter to shareholders: 10-Q: MISTRAS GROUP, INC.
Edgar Online - Thu Jan 09, 3:07PM CST
ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
